Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Dublin
- Most recent report
- 8-K, filed Sep 23, 2026
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1232524
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 47
News 8 of 121
- 8-K Significant contract Sep 23, 2026
- 8-K Current report on a material event Sep 15, 2026
- 8-K Significant contract Aug 31, 2026
- 8-K Other events Aug 25, 2026
- 8-K Significant contract Aug 10, 2026
- 8-K Current report on a material event Aug 10, 2026
- 8-K Quarterly results Aug 3, 2026
- 8-K Shareholder vote results Jul 24, 2026
Prospectuses and Registrations 8
- S-8 Registration statement for an employee plan Mar 2, 2022
- S-8 Registration statement for an employee plan May 7, 2021
- S-8 Registration statement for an employee plan Feb 23, 2021
- S-8 POS Post-effective amendment to an employee plan registration Nov 3, 2020
- S-8 Registration statement for an employee plan Nov 2, 2020
- S-8 Registration statement for an employee plan Feb 25, 2020
- S-8 Registration statement for an employee plan Feb 26, 2019
- S-8 Registration statement for an employee plan May 9, 2018
Proxies 8 of 48
- DEFA14A Extra proxy material Jul 14, 2026
- DEFA14A Extra proxy material Jun 8, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 8, 2026
- PRE 14A Preliminary proxy statement May 29, 2026
- DEFA14A Extra proxy material Jul 14, 2025
- DEFA14A Extra proxy material Jul 10, 2025
- DEFA14A Extra proxy material Jun 6, 2025
- DEF 14A Proxy statement for a shareholder vote Jun 6, 2025
Ownership 8 of 720
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 10, 2026
- 4 Insider reported a trade Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Sep 2, 2026
Other 8 of 56
- ARS Annual report sent to shareholders Jun 8, 2026
- UPLOAD Comment letter from SEC staff Aug 8, 2025
- CORRESP Reply to SEC staff Jul 29, 2025
- UPLOAD Comment letter from SEC staff Jul 17, 2025
- ARS Annual report sent to shareholders Jun 6, 2025
- SC TO-T/A Amended filing Apr 18, 2025
- SC TO-T/A Amended filing Apr 14, 2025
- SC TO-T/A Amended filing Apr 11, 2025
Everything here comes from Jazz Pharmaceuticals plc's own filings on SEC EDGAR. The filing list is rechecked every hour.